Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: J Immunol. 2013 Oct 14;191(10):10.4049/jimmunol.1300852. doi: 10.4049/jimmunol.1300852

Table 1.

Relevant epitopes used in this study.

Source Protein Abbreviation Sequence
VV Nonstructural protein A11R198-206 A11R AIVNYANL
VV E7R130-137 E7R STNLFNNL
VV B8R20-27 B8R TSYKFESV
LCMV Glycoprotein34-41 GP34 AVYNFATMa
LCMV Nucleoprotein205-212 NP205 YTVKYPNL
LCMV Nucleoprotein396-404 NP396 FQPQNGQFI
- Designed sequence SIY SIYRYYGL
- Ovalbumin257-264 OVA SIINFEKL
- Designed sequence OVA-AA SIINFAAL
- Designed sequence OVA-AT SIINFATL
a

This peptide carries a C-terminal Met -> Cys mutation relative to the native LCMV sequence. The substitution has been used in previous studies (44, 45) and does not have a significant impact on interaction with MHC or T cell receptors.